MoisesHarari TurquieMD
Oncology • Albuquerque, NMHead & Neck Cancer, Melanoma, Thoracic Cancer
Assistant Professor; Medical Oncology
Dr. Harari Turquie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 University of New Mexico
Albuquerque, NM 87131Phone+1 505-925-0405
Summary
- Moises Harari Turquie, MD is an experienced Oncologist based in Albuquerque, NM with subspecialties in Head & Neck Cancer, Melanoma, and Thoracic Cancer. He completed a Fellowship in Hematology and Medical Oncology at the University of New Mexico School of Medicine. His medical education began at Universidad La Salle School of Medicine and his Internal Medicine Internship was completed at HCA Florida JFK Hospital/University of Miami Miller School of Medicine GME Consortium. Dr. Harari Turquie has also made contributions to medical literature, with publications in the Journal of Investigative Medicine High Impact Case Reports and Case Reports in Oncology.
Education & Training
University of New Mexico School of MedicineFellowship, Hematology and Medical Oncology, 2019 - 2022
HCA Florida JFK Hospital/University of Miami Miller School of Medicine GME ConsortiumInternship, Internal Medicine, 2016 - 2019
Universidad La Salle School of MedicineClass of 2013
Certifications & Licensure
NM State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 11 citationsMetastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy.Shenthol Sasankan, Lorraine Rebuck, Gloria Darrah, Moises Harari Turquie, Ian Rabinowitz
Case Reports in Oncology. 2020-10-13 - The Equipoise Between the Treatment of Glioblastoma and the Risk of Secondary Acute Myelogenous Leukemia: An Illustrative Case Report.Moises Harari-Turquie, Krishna Rekha Moturi, Darrell D Horton, Ian Rabinowitz
Journal of Investigative Medicine High Impact Case Reports. 2023-08-19
Professional Memberships
- Member
- Member
Other Languages
- Spanish, Hebrew
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
